Company intelligence / Profile preview

MediMusic

East Yorkshire, England, United Kingdommedimusic.co ↗

Ownership: Private
Development stage: Commercial

Overview

Initial clinical trials with NHS partners have shown that MediMusic’s AI-generated playlists can reduce heart rate by up to 25% in people living with dementia. The technology is currently being trialed in UK care homes and hospitals. Results indicate significant potential for reducing anxiety and pain without medication.

Therapeutic areas: PsychiatryNeurology
Modalities: Non-pharmacological therapyDeviceDigital therapeutic platform
Industry: Digital Health Medical Devices

Partnerships

Warner Music Group (supporting expansion of hospital trials)Multiple NHS trusts & care home groupsAbbey Road Red tech incubator at Abbey Road Studios

Beyond the preview

Go deeper on MediMusic.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MediMusic.

Explore the full profile